down arrow

Biofil Chemicals

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE829A01014
  • NSEID: BIOFILCHEM
  • BSEID: 524396
INR
42.68
0.3 (0.71%)
BSENSE

Apr 11, 12:48 PM

BSE+NSE Vol: 8.46 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Biofil Chemicals & Pharmaceuticals Ltd stock-summary
stock-summary
Biofil Chemicals & Pharmaceuticals Ltd
Micro Cap
Pharmaceuticals & Drugs
Biofil Chemicals & Pharmaceuticals Limited (BCPL) was incorporated as a Private Limited Company on 4 Jan.'85 for manufacturing and trading of Pharmaceuticals products. Later on, the Company was converted into a Public Limited Company on 7 May '92. The Company deals in providing job work facility in respect of manufacturing of pharmaceuticals drug. It runs the business via two unit viz Pharmaceutical Division & Chemicals Division. In Feb.
Company Coordinates stock-summary
Company Details
11/12 Sector E Sanwer Road, Sanwer Road Industrial Area Indore Madhya Pradesh : 452015
stock-summary
Tel: 91-731-2426700
stock-summary
bcplcompliance@gmail.com
Registrar Details
Ankit Consultancy Pvt Ltd, Plot No 60, Electronic Complex, Pardeshipura, Indore
stock-summary Capital Structure
Capital Structure stock-summary
Present Equity Capital
INR 16.27 Cr
Number of Shares
1.63 Cr
Face Value
INR 10.0
Date
Number
of Shares(Cr)
Equity
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
31-Mar-2011
1.63
16.27
5712500
10
Reissue of Forfeited Shares
31-Mar-2011
1.63
16.27
5712500
10
Reissue of Forfeited Shares
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Non Institution

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 1 FIIs (0.0%)

Promoter with highest holding

Scope Finance Company Private Limited (13.9%)

Highest Public shareholder

Starline Equifin Private Limited (7.51%)

Individual Investors Holdings

38.18%

stock-summary Board of Directors
stock-summary
stock-summary
Management
Designation
Remuneration
Ramesh Shah
Chairman & Managing Director
0
Romil Shah
Non Executive Director
0
Shaila Jain
Independent Director
0
Satish Beohar
Independent Director
0
Ashok Kumar Ramawat
Independent Director
0
Ketan Shah
Whole-time Director
17.4 lacs
Shweta Verma
Company Sec. & Compli. Officer
0
Gayatri Padiyar
Independent Director
0
stock-recommendationRaw Materials
Raw Materials Dashboard stock-summary
Raw Materials
Amount(Rs Cr)
% of RM Cost
 
Icon
No Data Available
stock-recommendation Finished Goods
Finished Goods Dashboard stock-summary
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Pharmaceuticals, Medicinal chemicals and Botanical Products - Traded
9.16
74.12%
Pharmaceuticals, Medicinal chemicals and Botanical Products
1.83
14.79%
Conversion Charges
1.37
11.08%
 
74.12
Pharmaceuticals, Medicinal chemicals and Botanical Products - Traded
25.88
Pharmaceuticals, Medicinal chemicals and Botanical Products - Traded
14.79
Pharmaceuticals, Medicinal chemicals and Botanical Products
85.21
Pharmaceuticals, Medicinal chemicals and Botanical Products
11.08
Conversion Charges
88.92
Conversion Charges
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
14 Cr
(Quarterly Results - Dec 2024)
Net Profit:
0 Cr
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 71 Cr (Micro Cap)

stock-summary
P/E

69.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.01

stock-summary
Return on Equity

3.26%

stock-summary
Price to Book

3.75